News

Moonshot AI accessed Nvidia's chips despite Chinese export ban, White House official says

NVDA, NVDAN, NVDACL, NVD, NVDD, AI, 1NVDA, 4NVDA, 0R1I, 918422, NVDAUS, NVDA0, NVDA1

A White House official said Moonshot AI, which released the powerful Kimi K3 model last week, accessed Nvidia's GB300 chips in Thailand.

Amazon's Bezos pushes Prime Video redesign focused on AI: Reuters

AMZN, AMZNN, AMZNCL, AMZD, AMZ, 1AMZN, 0R1O, 4AMZN, 0R1OL, AI, AMZNUS

Bezos pushed Prime Video head Mike Hopkins to overhaul the streaming service so that AI is front and center, Reuters reports.

RTX (RTX) Q2 Earnings and Revenues Surpass Estimates

RTX, LUNR

RTX (RTX) delivered earnings and revenue surprises of +13.86% and +8.21%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Teck Resources Ltd (TECK) Surpasses Q2 Earnings and Revenue Estimates

TECK, MTRN

Teck Resources (TECK) delivered earnings and revenue surprises of +80.52% and +12.63%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Independent Bank (IBCP) Surpasses Q2 Earnings and Revenue Estimates

IBCP, PRK

Independent Bank (IBCP) delivered earnings and revenue surprises of +5.88% and +5.63%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

China's Geely to make EVs at Ford plant in Spain under new joint venture

JYNT

Ford and Geely plan for the joint venture will begin operations in the first half of 2027, with the first new vehicles scheduled to roll off the line in 2028.

Rick Rieder says income investors are facing a new regime. Here’s where he is investing now

BLK, BLKN, BLK2, BLKUS

BlackRock's Rick Rieder sees opportunities for income in select areas of the market for the third quarter.

IRS chief Frank Bisignano may have misled Congress, Democrats say

The IRS alone hemorrhaged more than 31,000 employees as of January in President Trump's government cuts, according to the agency's inspector general.

Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials

6490, NLLRF

There are now positive results from five late-stage trials on retatrutide, which Lilly is positioning as the next pillar of its obesity portfolio.

Ozempic face? Botox maker reports boost from 'sagging face' trend

GLP

The aestetics company hope increased GLP-1 use will fuel demand for treatments addressing facial volume loss, sometimes dubbed "Ozempic face."